Curasight AS (XSAT:CURAS) Current Deferred Revenue : kr0.00 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Curasight AS Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Curasight AS's current deferred revenue for the quarter that ended in Mar. 2025 was kr0.00 Mil.

Curasight AS Current Deferred Revenue Historical Data

The historical data trend for Curasight AS's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curasight AS Current Deferred Revenue Chart

Curasight AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Current Deferred Revenue

Get a 7-Day Free Trial

Curasight AS Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Current Deferred Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Curasight AS Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Curasight AS's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Curasight AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curasight AS (XSAT:CURAS) » Definitions » Current Deferred Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ole Maaloes Vej 3, Kobenhavn N, Kobenhavn, DNK, DK-2200

Website

https://www.curasight.com

Curasight AS is a clinical-stage biotech company committed to improving both the diagnosis and the treatment of certain types of cancer. The company is focused on generating data with both uTRACE and uTREAT in cancers, including prostate cancer and glioblastoma (brain cancer), neuroendocrine tumors (NET), head and neck cancer, non small cell lung cancer (NSCLC), and pancreatic cancer.

Curasight AS Headlines

No Headlines